{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T04:50:44Z","timestamp":1750308644998,"version":"3.41.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the National Medical Association"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jnma.2025.04.006","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T20:20:38Z","timestamp":1747167638000},"page":"179-184","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Systemic sclerosis and scleroderma renal crisis in African American patients"],"prefix":"10.1016","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-4248-2871","authenticated-orcid":false,"given":"Riti","family":"Kotamarti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9780-7171","authenticated-orcid":false,"given":"Kevin V.","family":"Hackshaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jnma.2025.04.006_bib0001","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/kjm2.12505","article-title":"Pathophysiology of systemic sclerosis (scleroderma)","volume":"38","author":"Rosendahl","year":"2022","journal-title":"Kaohsiung J Med Sci"},{"issue":"2_Part_1","key":"10.1016\/j.jnma.2025.04.006_bib0002","doi-asserted-by":"crossref","first-page":"305","DOI":"10.7326\/0003-4819-57-2-305","article-title":"An historical account of the study of progressive systemic sclerosis (Diffuse scleroderma)","volume":"57","author":"Rodnan","year":"1962","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.jnma.2025.04.006_bib0003","first-page":"47","article-title":"From Thibierge-Weissenbach syndrome (1910) to anti-centromere antibodies (1980). Clinical and biological features of scleroderma","volume":"150","author":"Meyer","year":"1999","journal-title":"Ann Med Interne (Paris)"},{"issue":"7","key":"10.1016\/j.jnma.2025.04.006_bib0004","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.3899\/jrheum.151353","article-title":"The frequency of scleroderma renal crisis over time: a metaanalysis","volume":"43","author":"Turk","year":"2016","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.jnma.2025.04.006_bib0005","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/acr.24807","article-title":"Association of race and risk of future scleroderma renal crisis at systemic sclerosis diagnosis","volume":"75","author":"Forman","year":"2022","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"51","key":"10.1016\/j.jnma.2025.04.006_bib0006","doi-asserted-by":"crossref","first-page":"e8980","DOI":"10.1097\/MD.0000000000008980","article-title":"Clinical and serological features of systemic sclerosis in a multicenter African American cohort","volume":"96","author":"Morgan","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.jnma.2025.04.006_bib0007","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1172\/JCI31139","article-title":"Systemic sclerosis: a prototypic multisystem fibrotic disorder","volume":"117","author":"Varga","year":"2007","journal-title":"J Clin Investig"},{"issue":"3","key":"10.1016\/j.jnma.2025.04.006_bib0008","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s12016-022-08945-x","article-title":"Renal disease and systemic sclerosis: an update on scleroderma renal crisis","volume":"64","author":"Cole","year":"2022","journal-title":"Clin Rev Allergy Immunol"},{"issue":"10","key":"10.1016\/j.jnma.2025.04.006_bib0009","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/rheumatology\/keh671","article-title":"Classification of systemic sclerosis. Visions and reality**Dedicated to the memory of E. Carwile LeRoy, 1933\u20132002","volume":"44","author":"Wollheim","year":"2005","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.jnma.2025.04.006_bib0010","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3390\/biomedicines10010163","article-title":"Systemic sclerosis: from pathophysiology to novel therapeutic approaches","volume":"10","author":"Benfaremo","year":"2022","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.jnma.2025.04.006_bib0011","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/ar4230","article-title":"Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells","volume":"15","author":"Gilbane","year":"2013","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.jnma.2025.04.006_bib0012","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1159\/000507886","article-title":"Renal involvement in Systemic sclerosis: an update","volume":"45","author":"Chrab\u0105szcz","year":"2020","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.jnma.2025.04.006_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2010\/543704","article-title":"Scleroderma renal crisis: a pathology perspective","volume":"2010","author":"Batal","year":"2010","journal-title":"Int J Rheumatol"},{"issue":"1","key":"10.1016\/j.jnma.2025.04.006_bib0014","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3899\/jrheum.171186","article-title":"Risk factors for future scleroderma renal crisis at Systemic sclerosis diagnosis","volume":"46","author":"Gordon","year":"2018","journal-title":"J Rheumatol"},{"issue":"51","key":"10.1016\/j.jnma.2025.04.006_bib0015","first-page":"134","article-title":"The genetics of systemic sclerosis","volume":"10","author":"Agarwal","year":"2010","journal-title":"Discov Med"},{"issue":"9","key":"10.1016\/j.jnma.2025.04.006_bib0016","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.3390\/jcm11092299","article-title":"Systemic scleroderma\u2014definition, clinical picture and laboratory diagnostics","volume":"11","author":"Kowalska-K\u0119pczy\u0144ska","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.jnma.2025.04.006_bib0017","first-page":"10","article-title":"Emerging treatments for scleroderma\/systemic sclerosis","author":"Zhu","year":"2021","journal-title":"Fac Rev"},{"issue":"3","key":"10.1016\/j.jnma.2025.04.006_bib0018","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/BOR.0000000000000795","article-title":"Treatment for systemic sclerosis-associated interstitial lung disease","volume":"33","author":"Roofeh","year":"2021","journal-title":"Curr Opin Rheu-matol"},{"key":"10.1016\/j.jnma.2025.04.006_bib0019","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keaa827","article-title":"Health-related quality of life in patients with systemic sclerosis: evolution over time and main determinants","author":"Van Leeuwen","year":"2021","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.jnma.2025.04.006_bib0020","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/2397198318758607","article-title":"Kidney involvement in systemic sclerosis: from pathogenesis to treatment","volume":"3","author":"Bruni","year":"2018","journal-title":"J Scleroderma Relat Disord"},{"issue":"11","key":"10.1016\/j.jnma.2025.04.006_bib0021","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"Van Den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.jnma.2025.04.006_bib0022","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1590\/abd1806-4841.20152890","article-title":"Localized scleroderma: clinical spectrum and therapeutic update","volume":"90","author":"Careta","year":"2015","journal-title":"An Bras Dermatol"},{"issue":"5","key":"10.1016\/j.jnma.2025.04.006_bib0023","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jaad.2021.10.065","article-title":"Systemic sclerosis in adults. Part I: clinical features and pathogenesis","volume":"87","author":"Jerjen","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jnma.2025.04.006_bib0024","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.semarthrit.2014.12.001","article-title":"Scleroderma renal crisis","volume":"44","author":"Bose","year":"2015","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.jnma.2025.04.006_bib0025","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3899\/jrheum.180582","article-title":"Scleroderma renal crisis: risk factors for an increasingly rare organ complication","volume":"47","author":"Moinzadeh","year":"2019","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.jnma.2025.04.006_bib0026","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/2397198318758607","article-title":"Kidney involvement in systemic sclerosis: from pathogenesis to treatment","volume":"3","author":"Bruni","year":"2018","journal-title":"J Scleroderma Relat Disord"},{"issue":"7","key":"10.1016\/j.jnma.2025.04.006_bib0027","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.3899\/jrheum.091165","article-title":"Characteristics of Joint Involvement and Relationships with Systemic Inflammation in Systemic Sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) Database","volume":"37","author":"Avouac","year":"2010","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.jnma.2025.04.006_bib0028","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00296-010-1697-6","article-title":"Corticosteroids and the risk of scleroderma renal crisis: a systematic review","volume":"32","author":"Trang","year":"2010","journal-title":"Rheumatol Int"},{"issue":"7","key":"10.1016\/j.jnma.2025.04.006_bib0029","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/ard.2006.066068","article-title":"Changes in causes of death in systemic sclerosis, 1972-2002","volume":"66","author":"Steen","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.jnma.2025.04.006_bib0030","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1093\/ndt\/gfs317","article-title":"Prognosis of scleroderma renal crisis: a long-term observational study","volume":"27","author":"Cozzi","year":"2012","journal-title":"Nephrol Dialysis Transpl"},{"issue":"4","key":"10.1016\/j.jnma.2025.04.006_bib0031","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/MD.0b013e31829be125","article-title":"Race and association with disease manifestations and mortality in scleroderma","volume":"92","author":"Gelber","year":"2013","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"10.1016\/j.jnma.2025.04.006_bib0032","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1002\/art.34482","article-title":"A clinical and serologic comparison of African American and Caucasian patients with systemic sclerosis","volume":"64","author":"Steen","year":"2012","journal-title":"Arthritis Rheumatism"},{"issue":"1","key":"10.1016\/j.jnma.2025.04.006_bib0033","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/2397198320920422","article-title":"Mortality and morbidity in scleroderma renal crisis: a systematic literature review","volume":"6","author":"Kim","year":"2020","journal-title":"J Scleroderma Relat Disord"},{"issue":"9","key":"10.1016\/j.jnma.2025.04.006_bib0034","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/acr.23861","article-title":"Increased morbidity and mortality of scleroderma in African Americans compared to Non\u2013African Americans","volume":"71","author":"Moore","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"10.1016\/j.jnma.2025.04.006_bib0035","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s11926-003-0045-1","article-title":"Ethnicity and race and systemic sclerosis: how it affects susceptibility, severity, antibody genetics, and clinical manifestations","volume":"5","author":"Reveille","year":"2003","journal-title":"Curr Rheumatol Rep"},{"issue":"3","key":"10.1016\/j.jnma.2025.04.006_bib0036","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1177\/2397198319855872","article-title":"Epigenetics of scleroderma: integrating genetic, ethnic, age, and environmental effects","volume":"4","author":"Ramos","year":"2019","journal-title":"J Scleroderma Relat Disord"},{"key":"10.1016\/j.jnma.2025.04.006_bib0037","article-title":"Racial\/ethnic differences in clusters of adverse childhood experiences and associations with adolescent mental health","volume":"17","author":"Zhang","year":"2022","journal-title":"SSM-Popul Health"},{"issue":"6","key":"10.1016\/j.jnma.2025.04.006_bib0038","first-page":"306","article-title":"Association of race and age with survival among patients undergoing dialysis","author":"Kucirka","year":"2011","journal-title":"JAMA"},{"year":"2023","series-title":"Poverty in the United States: 2022 (Report No. P60-280)","key":"10.1016\/j.jnma.2025.04.006_bib0039"},{"issue":"4","key":"10.1016\/j.jnma.2025.04.006_bib0040","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/art.38994","article-title":"Clinical and immunologic predictors of scleroderma renal crisis in Japanese systemic sclerosis patients with anti\u2013RNA polymerase III autoantibodies","volume":"67","author":"Hamaguchi","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.jnma.2025.04.006_bib0041","first-page":"20","article-title":"Prognostic profile of systemic sclerosis: analysis of the clinical EUSTAR cohort in China","author":"Hu","year":"2018","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.jnma.2025.04.006_bib0042","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.semarthrit.2009.06.002","article-title":"Survival, causes of death, and risk factors associated with mortality in Spanish systemic sclerosis patients: results from a single University Hospital","volume":"39","author":"Joven","year":"2010","journal-title":"Semin Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.jnma.2025.04.006_bib0043","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1007\/s10067-011-1751-0","article-title":"Gender and ethnicity differences in the prevalence of scleroderma-related autoantibodies","volume":"30","author":"Krzyszczak","year":"2011","journal-title":"Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.jnma.2025.04.006_bib0044","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s10067-019-04806-9","article-title":"Analysis of anti-RNA polymerase III antibodies in Chinese Han Systemic Sclerosis patients","volume":"39","author":"Liu","year":"2019","journal-title":"Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.jnma.2025.04.006_bib0045","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3899\/jrheum.080915","article-title":"Ethnic influence on disease manifestations and autoantibodies in Chinese-descent patients with systemic sclerosis","volume":"36","author":"LOW","year":"2009","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.jnma.2025.04.006_bib0046","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/pin.13221","article-title":"Antinuclear antibody pattern and autoantibody profiling of systemic sclerosis patients in a tertiary referral center in North India","volume":"72","author":"Machhua","year":"2022","journal-title":"Pathol Int"},{"issue":"5","key":"10.1016\/j.jnma.2025.04.006_bib0047","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1053\/sarh.2001.20268","article-title":"Systemic sclerosis in 3 US ethnic groups: a comparison of clinical, sociodemographic, serologic, and immunogenetic determinants","volume":"30","author":"Reveille","year":"2001","journal-title":"Semin Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.jnma.2025.04.006_bib0048","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3109\/08916934.2011.592886","article-title":"Distinctive autoantibody profile in Mexican mestizo systemic sclerosis patients","volume":"44","author":"Rodriguez-Reyna","year":"2011","journal-title":"Autoimmunity"},{"issue":"8","key":"10.1016\/j.jnma.2025.04.006_bib0049","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1136\/ard.2009.111310","article-title":"Association of STAT4 polymorphism with systemic sclerosis in a Japanese population","volume":"68","author":"Tsuchiya","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.jnma.2025.04.006_bib0050","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s10067-012-2145-7","article-title":"Clinical and serological features of systemic sclerosis in a Chinese cohort","volume":"32","author":"Wang","year":"2012","journal-title":"Clin Rheumatol"}],"container-title":["Journal of the National Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0027968425000288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0027968425000288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T19:24:04Z","timestamp":1750274644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0027968425000288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0027968425000288"],"URL":"https:\/\/doi.org\/10.1016\/j.jnma.2025.04.006","relation":{},"ISSN":["0027-9684"],"issn-type":[{"type":"print","value":"0027-9684"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic sclerosis and scleroderma renal crisis in African American patients","name":"articletitle","label":"Article Title"},{"value":"Journal of the National Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jnma.2025.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of National Medical Association.","name":"copyright","label":"Copyright"}]}}